Remove Generic Medicine Remove Information Remove Pharmaceutical Manufacturing
article thumbnail

Omnibus Spending Law: Provisions Will Bolster Medicines Supply Chain Insights and Advanced Manufacturing Technologies

Quality Matters

Department of Health and Human Services’ (HHS’) Administration for Strategic Preparedness and Response (ASPR) to prioritize identification of upstream pharmaceutical supply chain risks. Powered by more than 250 million data points spanning 92% of generic medicines approved in the U.S.,

article thumbnail

USP’s commitment to ESG considerations for a healthier, more sustainable world

Quality Matters

While reflecting the positive impacts of USP focus areas, in many cases these efforts also will facilitate data collection, target setting, and information sharing that can help USP stakeholders meet their own ESG goals. These USP documentary standards are recognized in U.S. josh.levin@usp.org Thu, 04/18/2024 - 12:57 USP Leadership

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What a mild recession could mean for small biotechs in 2023

Pharmaceutical Technology

To build an advanced pharmaceutical manufacturing cluster in the Richmond-Petersburg area, the Alliance for Building Better Medicine aims to support the early growth of local pharmaceutical manufacturers. The US Department of Commerce’s Economic Development Administration (EDA) awarded the organization $52.9

article thumbnail

Pharmaceutical Continuous Manufacturing: Regulatory landscape in the spotlight at USP workshop

Quality Matters

For example, while some stakeholders may perceive PCM to be primarily for innovators and not for makers of generic medicines or biotech companies, it “can be for generic companies, biotechnology companies, and so on, and we have had engagements with generic drug companies in our emerging technologies program already,” Fisher said.

article thumbnail

Accelerating pharma’s sustainability efforts

Express Pharma

Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4

Packaging 102
article thumbnail

Manufacturing solutions are essential to strengthen the global medicines supply chain

Quality Matters

government’s fiscal 2023 funding bill , signed into law in December 2022, included a range of specific provisions to support medicines supply chain resilience, including those supporting development of AMT through creation of national centers of excellence. The non-profit maker of essential generic medicines was established by a group of U.S.